Xiang Wang
Clinician Investigator, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Clinical Pharmacist, Pharmacy
The Ottawa Hospital
Scientific Advisor
Canadian Agency for Drugs and Technologies in Health
Clinical Instructor, PHM653, PHM301
University of Toronto, Leslie Dan Faculty of Pharmacy
Research Interests
Brief Biography
Selected Publications
1. Karnieg T and Wang X. Five things to know about Cytisine. CMAJ, May 14, 2018 190 (19) E596.
[http://www.cmaj.ca/content/190/19/E596]
2. Wang X and Karnieg T. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation; N Engl J Med 2018; 378:484-486. [http://www.nejm.org/doi/full/10.1056/NEJMc1715183]
3. Iwona Bielska, Xiang Wang et al The Health Economics of Ankle and Foot Sprains and Fractures: A Systematic Review of English-Language Published Papers. Part 1: The Direct and Indirect Costs of Injury, the Foot. 2017. [https://www.ncbi.nlm.nih.gov/pubmed/29108669]
4. Iwona Bielska, Xiang Wang et al The Health Economics of Ankle and Foot Sprains and Fractures: A Systematic Review of English-Language Published Papers. Part 2: The Direct and Indirect Costs of Injury, the Foot. 2017. [https://www.ncbi.nlm.nih.gov/pubmed/29174064]
5. Wang X, Lavigne E, Ouellette-Kuntz H, Chen BE: Acute impacts of extreme temperature exposure on emergency
room admissions related to mental and behavior disorders in Toronto, Canada. J Affect Disord 2014,
155:154-161. [https://www.ncbi.nlm.nih.gov/pubmed/24332428]
6. Lavigne E, Gasparinni A, Wang X et al.: Extreme ambient temperatures and cardiorespiratory emergency room
visits: assessing risk by comorbid health conditions in a time series study. Environmental Health 2014. [https://www.ncbi.nlm.nih.gov/pubmed/24484632].
Diseases, conditions and populations of interest
Research and clinical approaches
